Laddar...

Integrin β1-mediated acquired gefitinib resistance in non-small cell lung cancer cells occurs via the phosphoinositide 3-kinase-dependent pathway

The present study aimed to explore the role of integrin β1 and the relevant signaling pathways in acquired gefitinib resistance in non-small cell lung cancer (NSCLC). The inhibitory effects of gefitinib, with or without LY294002, on cellular proliferation were evaluated by 3-(4,5-dimethylthiazol-2-y...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Oncol Lett
Huvudupphovsmän: DENG, QIN-FANG, SU, BO, ZHAO, YIN-MIN, TANG, LIANG, ZHANG, JIE, ZHOU, CAI-CUN
Materialtyp: Artigo
Språk:Inglês
Publicerad: D.A. Spandidos 2016
Ämnen:
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC4727211/
https://ncbi.nlm.nih.gov/pubmed/26870244
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ol.2015.3945
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!